RecruitingNCT07345312

BodySleep Algorithm for OSA Diagnosis in Children

The Use of the BodySleep Algorithm (ResMed) for the Diagnosis of Obstructive Sleep Apnea Syndrome in Children


Sponsor

Central Hospital, Nancy, France

Enrollment

90 participants

Start Date

Jan 10, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

Diagnosing obstructive sleep apnea-hypopnea syndrome in children (OSA) requires the performance of polysomnography (PSG) in the hospital which is sometimes challenging to perform in children, and time-consuming for installation and analysis. Simplified recording and analysis methods are preferable in children but require validation in this population. The BodySleep automatic algorithm of the polysomnograph used in our lab (A1-Nox, ResMed) associated only with respiratory signals could be used to identify respiratory events. Thus the child would have fewer sensors installed on him.


Eligibility

Min Age: 2 YearsMax Age: 18 Years

Inclusion Criteria2

  • Children suspected of OSA who are addressed for a PSG by the ear nose throat physician, pediatric pulmonologist, neurologist, psychiatrist, sleep specialist, genetics, and nutritionist physician.
  • Age between 2 and 18 years

Exclusion Criteria1

  • Age under 2 years and over 18 years

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPolysomnography

PSG performed prospectively in routine care in children suspected of OSA


Locations(1)

CHRU de Nancy

Nancy, Grand Est, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07345312


Related Trials